Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2000
12/14/2000WO2000074717A1 NOVEL Ig FRACTIONS HAVING AN IMMUNOMODULATORY ACTIVITY
12/14/2000WO2000074706A1 Therapeutic use of an inhibitor of a hedgehog or a hedgehog-related signalling pathway
12/14/2000WO2000074687A1 Antisense modulation of b7 protein expression
12/14/2000WO2000074671A1 Method and markers for prognosticating efficacy of anticancer agents
12/14/2000WO2000074646A2 Novel liposomal vector complexes and their use in gene therapy
12/14/2000WO2000074635A2 Delivery of single stranded dna for expression
12/14/2000WO2000074630A2 Dna vaccine for protecting an avian against infectious bursal disease virus
12/14/2000WO2000074629A2 Composition for implementing a cytotoxic, in particular an antitumoral or antiviral, treatment in a mammal
12/14/2000WO2000074485A1 Estrogen receptor site-specific ribozymes and uses thereof for estrogen dependent tumors
12/14/2000WO2000074477A1 Process for reconstructing a non-human animal embryo by nuclear transfer and preparing the animal therefrom, and embryos and animals obtained thereby
12/14/2000WO2000063419B1 Combinatorial chemical library supports having indicia at coding positions and methods of use
12/14/2000WO2000053776A3 Human kallikrein-like genes
12/14/2000WO2000053775A3 Prevention and treatment of viral infections
12/14/2000WO2000053749A3 Vascular adhesion molecules and modulation of their function
12/14/2000WO2000050614A3 Methods of using viral replicase polynucleotides and polypeptides
12/14/2000WO2000050613A3 Transgenic plants and method for transforming carnations
12/14/2000WO2000050612A3 Recombinant protein c activator and uses therefor
12/14/2000WO2000050588A3 Genes associated with diseases of the colon
12/14/2000WO2000050564A3 Method for extracting dna from dried specimens
12/14/2000WO2000050562A3 Dna encoding snorf25 receptor
12/14/2000WO2000049178A3 Polynucleotide sequencing method
12/14/2000WO2000049039A3 Glucose dehydrogenase fusion proteins and their utilization in expression systems
12/14/2000WO2000047748A3 Udp-glucose modifiers
12/14/2000WO2000047747A3 Maize glutathione-s-transferase enzymes
12/14/2000WO2000047714A3 Isolation and characterization of heat shock protein
12/14/2000WO2000047612A3 Structure-based screening techniques for drug discovery
12/14/2000WO2000047231A3 Novel antisense inhibition of rad51
12/14/2000WO2000047229A3 Polynucleotide encoding multimers of antigenic peptides in order to enhance presentation of the antigenic peptide by mhc molecules
12/14/2000WO2000046386A3 Gene repair involving the induction of double-stranded dna cleavage at a chromosomal target site
12/14/2000WO2000046236A3 Novel rgs-containing molecules and uses thereof
12/14/2000WO2000043498A3 Human liver progenitors
12/14/2000WO2000043032A3 Baff, inhibitors thereof and their use in the modulation of b-cell response
12/14/2000WO2000042203A3 Methods for producing polypeptides in cyclohexadepsipeptide-deficient cells
12/14/2000WO2000042063A3 Peptides for inhibiting hbv core proteins
12/14/2000WO2000033872A9 Method of and compositions for immunization with the pseudomonas v antigen
12/14/2000WO1999055894A9 Construction of retroviral producer cells from adenoviral and retroviral vectors
12/14/2000DE19926771A1 Nukleinsäuremoleküle aus Weizen, transgene Pflanzenzellen und Pflanzen und deren Verwendung für die Herstellung modifizierter Stärke Nucleic acid molecules from wheat, transgenic plant cells and plants and their use for the production of modified starch
12/14/2000DE19926770A1 Nukleinsäurefragment und Vektor, enthaltend eine Halogenase, sowie ein Verfahren zur Halogenierung chemischer Verbindungen A nucleic acid fragment and vector containing a halogenase, and a process for the halogenation of chemical compounds
12/14/2000DE19926456A1 Verfahren zur Erhöhung des Fettsäuregehalts in Pflanzensamen A method of increasing the fatty acid content in plant seeds
12/14/2000DE19926083A1 Biologisches Gelenkkonstrukt The biological joint construct
12/14/2000DE19925862A1 Verfahren zur Synthese von DNA-Fragmenten Process for the synthesis of DNA fragments
12/14/2000CA2588221A1 Modified chimeric polypeptides with improved pharmacokinetic properties
12/14/2000CA2504679A1 Compositions and methods for the treatment of tumor
12/14/2000CA2501815A1 Compositions and methods for the treatment of tumor
12/14/2000CA2383828A1 26 human secreted proteins
12/14/2000CA2378822A1 Solid phase methods for amplifying multiple nucleic acids
12/14/2000CA2376939A1 Herpes simplex virus expressing foreign genes and method for treating cancers therewith
12/14/2000CA2376790A1 Siv-based packaging-defficient vectors
12/14/2000CA2376665A1 Novel tet repressor-based transcriptional regulatory proteins
12/14/2000CA2376663A1 Suppressor of cytokine signaling (socs)-3 promoter and methods for its use
12/14/2000CA2376642A1 Recombinant nematode nicotinic receptor and uses
12/14/2000CA2376638A1 Muteins of bilin-binding protein
12/14/2000CA2376634A1 Immunostimulant oligonucleotide
12/14/2000CA2376438A1 Identification of compounds that modify transcriptional responses to hypoxia
12/14/2000CA2376400A1 Compounds and methods to enhance raav transduction
12/14/2000CA2376335A1 Novel ig fractions having an immunomodulatory activity
12/14/2000CA2376314A1 Apoptosis inhibition by adenovirus e3/6.7k
12/14/2000CA2376210A1 Therapeutic use of an inhibitor of a hedgehog or a hedgehog-related signalling pathway
12/14/2000CA2376192A1 Streptavidin expressed gene fusions and methods of use thereof
12/14/2000CA2376189A1 Production by yeast cells of aspartic proteinases from plant origin with proteolytic activity
12/14/2000CA2376078A1 Peptide having for fibrinogen fragment e activity, analogs, antibodies and uses thereof
12/14/2000CA2376062A1 Fusion proteins comprising a fragment of a chaperon polypeptide
12/14/2000CA2376058A1 Use of the regulatory subunit of the camp dependent protein kinase (pka) from dictyostelium for camp measurements
12/14/2000CA2376055A1 Spliceosomal protein and its use
12/14/2000CA2376018A1 Angiogenic proteins and uses thereof
12/14/2000CA2375876A1 An integrin heterodimer and an alpha subunit thereof
12/14/2000CA2375861A1 Method and markers for prognosticating efficacy of anticancer agents
12/14/2000CA2375854A1 Novel liposomal vector complexes and their use in gene therapy
12/14/2000CA2375627A1 Polyepitopic protein fragments of the e6 and e7 proteins of hpv, their production and their use particularly in vaccination
12/14/2000CA2375617A1 Targeted angiogenesis
12/14/2000CA2375602A1 Polyepitopic proteinic fragments of the hiv nef protein, production and use thereof in vaccinations
12/14/2000CA2375540A1 Nucleic acid sequences encoding proteins involved in fatty acid beta-oxidation and methods of use
12/14/2000CA2375441A1 Methods for manipulating the avian genome
12/14/2000CA2375433A1 Transcription-based gene mapping
12/14/2000CA2375424A1 Novel polynucleotides and polypeptides encoded thereby
12/14/2000CA2375409A1 Compositions affecting programmed cell death and their use in the modification of forestry plant development
12/14/2000CA2375145A1 Substrate trapping protein tyrosine phosphatases
12/14/2000CA2375098A1 Compositions and methods useful for production of recombinant viruses which require helper viruses
12/14/2000CA2374851A1 Tek antagonists
12/14/2000CA2374664A1 In vivo selection method for determining inhibitory rna molecules
12/14/2000CA2374587A1 Hybridomas for lung cancer marker and monoclonal antibodies thereof
12/14/2000CA2374558A1 Phospholipid transfer protein
12/14/2000CA2371434A1 Compositions and methods for the treatment of tumor
12/14/2000CA2339900A1 Composition for implementing a cytotoxic, in particular an antitumoral or antiviral, treatment in a mammal
12/14/2000CA2339517A1 Engineering .beta.-ketoacyl acp synthase for novel substrate specificity
12/14/2000CA2339255A1 Hepg2 cells stably transfected with hcv
12/14/2000CA2336590A1 Hybrid yeast-bacteria cloning system and uses thereof
12/13/2000EP1059533A1 Method for immunochemically assaying anti-hm1.24 antibody
12/13/2000EP1059523A2 Automated real-time analysis of nucleic acid amplification
12/13/2000EP1059358A1 Penicillin binding protein gene and process for producing l-glutamic acid
12/13/2000EP1059357A1 Replicating or semi-replicating retroviral constructs, preparation and uses for gene delivery
12/13/2000EP1059356A1 Replicating or semi-replicating retroviral constructs, preparation and uses for gene delivery
12/13/2000EP1059355A1 Bacteriocin, its preparation and use
12/13/2000EP1059354A2 Sequence-determined DNA fragments and corresponding polypeptides encoded thereby
12/13/2000EP1059353A2 Novel calpain and dna encoding the same
12/13/2000EP1059088A1 New Ig-fractions with immunomodulation activity
12/13/2000EP1058851A1 Magnetic particle transfer device and method
12/13/2000EP1058742A1 Screening for functional antisense agents
12/13/2000EP1058741A1 Screening for functional antisense agents
12/13/2000EP1058739A1 Method for generating gene expression profiles
1 ... 3141 3142 3143 3144 3145 3146 3147 3148 3149 3150 3151 3152 3153 3154 3155 3156 3157 3158 3159 3160 3161 ... 4023